A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL

NCT01483690 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped Toxicity

Conditions

Acute Lymphoblastic Leukemia
Precursor B-Cell Lymphoblastic Leukemia
Precursor T-Cell Lymphoblastic Leukemia

Interventions

DRUG: Decitabine
DRUG: Vorinostat
DRUG: Vincristine
DRUG: Dexamethasone
DRUG: Mitoxantrone
DRUG: Pegaspargase
DRUG: Methotrexate

Sponsor

Therapeutic Advances in Childhood Leukemia Consortium